Metamizole: EMA wants to reduce the risk of agranulocytosis
Amsterdam – Reports of agranulocytosis have prompted the Pharmacovigilance Committee (PRAC) of the European Medicines Agency (EMA) to update the product information for painkillers containing the active ingredient metamizole. The reason was an application from